Keytruda (pembrolizumab) plus Lenvima (lenvatinib) and chemotherapy improved progression-free survival but did not achieve ...

Extended collaboration will further explore the capabilities of Medidata Platform from early-phase trials to post-marketing ...

In this video interview, Dipanwita Das, CEO & co-founder at Sorcero, highlights how artificial intelligence, real-time ...

Use of decentralized approach in a Phase 1 pharmacokinetic trial shows the ability to enable remote data collection and ...

End-to-end offering is designed to streamline site activation and optimize visibility in critical research processes.

“The goal is to develop life-saving medications for patients faster. That comes down to saving time and money,” said Bonne ...

In this video interview, Dipanwita Das, CEO & co-founder at Sorcero, highlights increased data management, DE&I, and ...

In this video interview, Dipanwita Das, CEO & co-founder at Sorcero, discusses challenges such as high costs and long ...

Investigators find that most exclusion criteria in critical care randomized clinical trials are justifiable, but 60% include ...

In this video interview, Dipanwita Das, CEO & co-founder at Sorcero, looks back to 2024 and discusses some of the industry’s ...

Phase III HELIOS-B trial found that Amvuttra (vutrisiran) also preserved functional capacity and quality of life in patients ...

In the pivotal trial, patients treated with Omvoh experienced significant improvements in clinical remission and endoscopic ...